KATHERINE GRIMES: Open Payments
NPI 1023620457 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 29 payments from 10 companies in 2025. Trend: 2023 $1,754 · 2024 $1,045 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 6 | $327 |
| Collegium Pharmaceutical, Inc. | 15 | $255 |
| Medtronic, Inc. | 1 | $58 |
| Abbott Laboratories | 1 | $30 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| Averitas Pharma Inc. | 1 | $20 |
| PROTEGA PHARMACEUTIALS INC | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Foundation Fusion Solutions, LLC | 1 | $9 |
Products named: Intracept, Belbuca, INTELLIS ADAPTIVESTIM, ETERNA, XTAMPZA, JOURNAVX, QUTENZA, ROXYBOND.
Industry payments across AZ — which companies pay providers there.
